RESEARCH ARTICLE in Cell Reports, May 2024
Together with Boehringer Ingelheim, Myllia performed a CROP-Seq screen contributing to the publication: "Genetic dependencies associated with transcription factor activities in human cancer cell lines" in Cell Reports, May 2024
SUMMARY
Transcription factors (TFs) are important mediators of aberrant transcriptional programs in cancer cells. In this study, we focus on TF activity (TFa) as a biomarker for cell-line-selective anti-proliferative effects, in that high TFa predicts sensitivity to loss of function of a given gene (i.e., genetic dependencies [GDs]). Our linear-regression-based framework identifies 3,047 pan-cancer and 3,952 cancer-type-specific candidate TFa-GD associations from cell line data, which are then cross-examined for impact on survival in patient cohorts. One of the most prominent biomarkers is TEAD1 activity, whose associations with its predicted GDs are validated through experimental evidence as proof of concept. Overall, these TFa-GD associations represent an attractive resource for identifying innovative, biomarker-driven hypotheses for drug discovery programs in oncology.
Lean more about the CROP-Seq screen (Figure 5) here, and download the article using your credentials below: